Results 141 to 150 of about 285,474 (314)

Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review. [PDF]

World J Diabetes, 2020
Zhang L, Xue S, Hou J, Chen G, Xu ZG.
europepmc   +1 more source

Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: Role of ETB-receptor expression levels

, 2009
Stéphanie Sauvageau, Éric Thorin, Louis Villeneuve, Jocelyn Dupuis   +3 more
openalex   +2 more sources

Edible Seeds in the Fight Against Hypertension: A Review of In Vitro, In Vivo, and Clinical Evidences With a Mechanistic Insight of Bioactive Compounds

Food Frontiers, Volume 7, Issue 1, January 2026.
The presented review provides the potential antihypertensive benefits of traditionally employed edible seeds, presenting new perspectives and avenues for future research. ABSTRACT Hypertension, often referred to as a silent killer, is responsible for 7.5 million deaths, representing approximately 12.8% of all global mortality.
Jinmin Shi, Mohamad Fawzi Mahomoodally, Ahmed Abduljalal Abduljabbar, Ruttun Bushra Umme Zainab, Katharigatta N. Venugopala, Gokhan Zengin, Sakina Yagi, Meng‐Yao Li, Xuebo Hu   +8 more
wiley   +1 more source

A review of pulmonary arterial hypertension: role of ambrisentan

Vascular Health and Risk Management, 2007
Robyn J BarstColumbia University College of Physicians & Surgeons, New York, NY, USAAbstract: Pulmonary arterial hypertension (PAH) is a rare fatal disease.
Robyn J Barst
doaj  

Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe? [PDF]

J Heart Lung Transplant, 2020
Badagliacca R, Sciomer S, Petrosillo N.
europepmc   +1 more source

Multiple Compound-Related Adverse Properties Contribute to Liver Injury Caused by Endothelin Receptor Antagonists

Journal of Pharmacology and Experimental Therapeutics, 2015
J. G. Kenna, Simone H. Stahl, Julie A. Eakins, Alison J. Foster, Linda C. Andersson, J. Bergare, M. Billger, M. Elebring, Charles S. Elmore, Richard A. Thompson   +9 more
semanticscholar   +1 more source

The biased apelin receptor agonist, MM07, reverses Sugen/hypoxia-induced pulmonary arterial hypertension as effectively as the endothelin antagonist macitentan [PDF]

Thomas Williams, Duuamene Nyimanu, Rhoda E. Kuc, Richard Foster, Robert C. Glen, Janet J. Maguire, Anthony P. Davenport   +6 more
openalex   +1 more source

Anti‐ulcerogenic properties of endothelin receptor antagonists in the rat [PDF]

, 1999
PADOL, Huang, John A. Hunt
openalex   +1 more source

P16‐69: Assessment of the effect of endothelin receptor antagonist in patients with less severe or severe pulmonary hypertension associated with interstitial lung disease [PDF]

, 2021
Susumu Sakamoto, Marie Masuoka, Muneyuki Sekiya, Yusuke Usui, Hiroshige Shimizu, Shion Miyoshi, Yasuhiko Nakamura, Naohisa Urabe, Takuma Isshiki, Kazutoshi Isobe, Yujiro Takai, Atsuko Kurosaki, Sakae Homma, Kazuma Kishi, Kimitaka Akaike, Koichi Saruwatari, Ryohei Matsushima, Kosuke Fujino, Seitaro Oda, Shinya Shiraishi, Hiroko Okabayashi, Shohei Hamada, Yusuke Tomita, Aiko Masunaga, Sho Saeki, Koei Ikeda, Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami   +28 more
openalex   +1 more source

Curcumin Protected CoCl2‐Induced Apoptosis and Ferroptosis in Human Umbilical Vein Endothelial Cells by Regulating the Expression of HSPA6

Food Science &Nutrition, Volume 14, Issue 1, January 2026.
Curcumin reduces the expression of MMP1 and MMP13 while increasing TIMP‐1 levels by downregulating HSPA6 in CoCl2‐induced HUVECs. This mechanism attenuates apoptosis, ferroptosis, and mitochondrial damage in HUVECs. These findings suggest that curcumin holds promise for the clinical treatment of hypoxia‐induced vascular diseases.
Ruihai Ye, Hang Lv, Zhe Ren, Xiaohong Yang, Xin Lv, Xue Xu   +5 more
wiley   +1 more source